Global Testosterone Injectable Market to Grow with a CAGR of ~4% During 2022-2031; Market to Grow on the Back of the Increasing Prevalence of High-Risk Testosterone Deficiency, and Advancement in Healthcare Infrastructure New York, July 19, 2022 (GLOBE NEWSWIRE) -- Hypogonadism is thought to affect 4 to 5 million men in the United States. Older men are particularly prone to have low testosterone levels. Free...